4//SEC Filing
Rosiello Robert L. 4
Accession 0000950170-25-104016
CIK 0001609809other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 4:10 PM ET
Size
5.4 KB
Accession
0000950170-25-104016
Insider Transaction Report
Form 4
Rosiello Robert L.
Director
Transactions
- Award
Stock Option (right to buy)
2025-08-05+10,000→ 10,000 totalExercise: $14.28Exp: 2035-08-05→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in four equal quarterly installments occurring on August 5, 2026, August 5, 2027, August 5, 2028, August 5, 2029, subject to the reporting person continuing in service on the Board as a non-employee director through the applicable vesting date.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001645041
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 4:10 PM ET
- Size
- 5.4 KB